NASDAQ: CGBDCarlyle Secured Lending Inc Stock
$10.95+0.09 (+0.83%)
Updated Jun 18, 2026
CGBD Price
$10.95
Fair Value Price
-$0.72
Market Cap
$760.99M
52 Week Low
$10.48
52 Week High
$14.49
P/E
15.42x
P/B
0.68x
P/S
2.93x
PEG
0.4x
Dividend Yield
14.61%
Revenue
$264.78M
Earnings
$51.70M
Gross Margin
78.2%
Operating Margin
53.99%
Profit Margin
19.5%
Debt to Equity
1.29
Operating Cash Flow
-$138M
Beta
0.58
Next Earnings
Aug 4, 2026
Ex-Dividend
Jun 30, 2026
Next Dividend
Jul 16, 2026
CGBD Overview
Carlyle Secured Lending, Inc. functions as a business development company, primarily making direct investments. The firm provides a diverse array of financing, including first and second lien senior secured loans, unsecured debt, mezzanine debt, and equity stakes. It focuses its investment efforts on the middle market segment. Industries of interest include healthcare and pharmaceuticals, aerospace and defense, high technology, business services, software, the beverage, food, and tobacco sectors, hospitality, gaming, and leisure, banking, finance, and insurance, and real estate. Geographically, Carlyle Secured Lending invests in companies located in the United States, Luxembourg, the Cayman Islands, Cyprus, and the United Kingdom. It typically targets businesses generating an EBITDA between $25 million and $100 million.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CGBD's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
D
CGBD
Ranked#58 of 80
Ranked#58 of 80
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $75.15 | A | |
| $8.15 | A | |
| $122.27 | B |
Be the first to know about important CGBD news, forecast changes, insider trades & much more!
CGBD News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CGBD scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CGBD ($10.95) is overvalued by 1,616.8% relative to our estimate of its Fair Value price of -$0.72 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CGBD ($10.95) is not significantly undervalued (1,616.8%) relative to our estimate of its Fair Value price of -$0.72 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CGBD ($10.95) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CGBD due diligence checks available for Premium users.
Valuation
CGBD fair value
Fair Value of CGBD stock based on Discounted Cash Flow (DCF)
Price
$10.95
Fair Value
-$0.72
Undervalued by
1,616.80%
CGBD ($10.95) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CGBD ($10.95) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CGBD ($10.95) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CGBD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.42x
Industry
34.34x
Market
9.47x
CGBD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CGBD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CGBD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.68x
Industry
2.69x
CGBD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CGBD price to earnings growth (PEG)
For valuing profitable companies with growth potential
CGBD is good value based... subscribe to Premium to read more.
PEG Value Valuation
CGBD's financial health
Profit margin
Revenue
$64.1M
Net Income
-$4.2M
Profit Margin
-6.6%
CGBD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.6B
Liabilities
$1.4B
Debt to equity
1.29
CGBD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CGBD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$212.4M
Investing
$0.0
Financing
-$191.6M
CGBD vs Asset Management Stocks
Carlyle Secured Lending Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.